We are live on ! Find out more
RCP

Rho Capital Partners Portfolio holdings

AUM $20.4M
This Fund
S&P 500
This Quarter Est. Return
-16.16%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$199M
AUM Growth
-$58.3M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
6
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 26.4%
2 Healthcare 11.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EVDY
1
DELISTED
Everyday Health, Inc.
EVDY
$82.5M 41.45%
5,908,432
IL
2
DELISTED
IntraLinks Holdings Inc.
IL
$52.6M 26.4%
6,490,503
ANAC
3
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
$26.1M 13.12%
1,067,892
TVRD
4
Tvardi Therapeutics
TVRD
$23.6M
$22.4M 11.24%
74,113
RLOC
5
DELISTED
REACHLOCAL INC COM STK (DE)
RLOC
$9.28M 4.66%
2,570,395
NRX
6
DELISTED
NEPHROGENEX INC COM
NRX
$6.21M 3.12%
1,326,826

Similar funds

Rho Capital Partners's Q3 2014 Portfolio in Review

As of Q3 2014, Rho Capital Partners held 6 positions worth $199M, down 23% from $257M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2014: portfolio turnover was 0%. Rho Capital Partners opened no new positions and made no exits, leaving the 6-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 22% a quarter earlier, followed by Healthcare.

  • Rho Capital Partners's ten largest holdings make up 100% of its $199M portfolio in Q3 2014.
  • Rho Capital Partners opened 0 new positions and closed 0 in Q3 2014.
  • Rho Capital Partners's portfolio value fell 23% quarter-over-quarter to $199M.

Based on Rho Capital Partners's 13F filing for Q3 2014, filed 10 Nov 2014.